OBJECT: Traumatic brain injury (TBI) induces significant neurological damage, including deficits in learning and memory, which contribute to a poor clinical prognosis. Treatment options to limit cognitive decline and promote neurological recovery are lacking, in part due to a poor understanding of the secondary or delayed processes that contribute to brain injury. In the present study, the authors characterized the temporal and spatial changes in the expression of postsynaptic density protein-95 (PSD-95), a key scaffolding protein implicated in excitatory synaptic signaling, after controlled cortical impacts in mice. Neurological injury, as assessed by the open-field activity test and the novel object recognition test, was compared with changes in PSD-95 expression. METHODS: Adult male CD-1 mice were subjected to controlled cortical impacts to simulate moderate TBI in humans. The spatial and temporal expression of PSD-95 was analyzed in the cerebral cortex and hippocampus at various time points following injury and sham operations. Neurological assessments were performed to compare changes in PSD-95 with cognitive deficits. RESULTS: A significant decrease in PSD-95 expression was observed in the ipsilateral hippocampus beginning on Day 7 postinjury. The loss of PSD-95 corresponded with a concomitant reduction in immunoreactivity for NeuN (neuronal nuclei), a neuron-specific marker. Aside from the contused cortex, a significant loss of PSD-95 immunoreactivity was not observed in the cerebral cortex. The delayed loss of hippocampal PSD-95 directly correlated with the onset of behavioral deficits, suggesting a possible causative role for PSD-95 in behavioral abnormalities following head trauma. CONCLUSIONS: A delayed loss of hippocampal synapses was observed following head trauma in mice. These data may suggest a cellular mechanism to explain the delayed learning and memory deficits in humans after TBI and provide a potential framework for further testing to implicate PSD-95 as a clinically relevant therapeutic target.
OBJECT: Traumatic brain injury (TBI) induces significant neurological damage, including deficits in learning and memory, which contribute to a poor clinical prognosis. Treatment options to limit cognitive decline and promote neurological recovery are lacking, in part due to a poor understanding of the secondary or delayed processes that contribute to brain injury. In the present study, the authors characterized the temporal and spatial changes in the expression of postsynaptic density protein-95 (PSD-95), a key scaffolding protein implicated in excitatory synaptic signaling, after controlled cortical impacts in mice. Neurological injury, as assessed by the open-field activity test and the novel object recognition test, was compared with changes in PSD-95 expression. METHODS: Adult male CD-1mice were subjected to controlled cortical impacts to simulate moderate TBI in humans. The spatial and temporal expression of PSD-95 was analyzed in the cerebral cortex and hippocampus at various time points following injury and sham operations. Neurological assessments were performed to compare changes in PSD-95 with cognitive deficits. RESULTS: A significant decrease in PSD-95 expression was observed in the ipsilateral hippocampus beginning on Day 7 postinjury. The loss of PSD-95 corresponded with a concomitant reduction in immunoreactivity for NeuN (neuronal nuclei), a neuron-specific marker. Aside from the contused cortex, a significant loss of PSD-95 immunoreactivity was not observed in the cerebral cortex. The delayed loss of hippocampal PSD-95 directly correlated with the onset of behavioral deficits, suggesting a possible causative role for PSD-95 in behavioral abnormalities following head trauma. CONCLUSIONS: A delayed loss of hippocampal synapses was observed following head trauma in mice. These data may suggest a cellular mechanism to explain the delayed learning and memory deficits in humans after TBI and provide a potential framework for further testing to implicate PSD-95 as a clinically relevant therapeutic target.
Authors: F Tomaiuolo; G A Carlesimo; M Di Paola; M Petrides; F Fera; R Bonanni; R Formisano; P Pasqualetti; C Caltagirone Journal: J Neurol Neurosurg Psychiatry Date: 2004-09 Impact factor: 10.154
Authors: Krishnan M Dhandapani; Martin Hadman; Liesl De Sevilla; Marlene F Wade; Virendra B Mahesh; Darrell W Brann Journal: J Biol Chem Date: 2003-07-29 Impact factor: 5.157
Authors: W L Maxwell; K Dhillon; L Harper; J Espin; T K MacIntosh; D H Smith; D I Graham Journal: J Neuropathol Exp Neurol Date: 2003-03 Impact factor: 3.685
Authors: Jens Bak Sommer; Anders Bach; Hana Malá; Mikko Gynther; Ann-Sofie Bjerre; Marie Gajhede Gram; Linda Marschner; Kristian Strømgaard; Jesper Mogensen; Darryl S Pickering Journal: Neurochem Res Date: 2017-08-21 Impact factor: 3.996
Authors: Denglei Ma; Na Wang; Xiaotong Fan; Lan Zhang; Yi Luo; Rui Huang; Li Zhang; Yali Li; Guoguang Zhao; Lin Li Journal: Neurochem Res Date: 2018-02-28 Impact factor: 3.996
Authors: Laura K Cole; Jin Hee Kim; Andrew A Amoscato; Yulia Y Tyurina; Hülya Bay R; Benyamin Karimi; Tabrez J Siddiqui; Valerian E Kagan; Grant M Hatch; Tiina M Kauppinen Journal: Biochim Biophys Acta Mol Basis Dis Date: 2018-07-25 Impact factor: 5.187
Authors: Jenhao H Ting; David R Marks; Stephanie S Schleidt; Joanna N Wu; Jacob W Zyskind; Kathryn A Lindl; Julie A Blendy; R Christopher Pierce; Kelly L Jordan-Sciutto Journal: J Neurochem Date: 2014-02-12 Impact factor: 5.372